Mutations to the HCoV-229E spike have counterbalancing effects on serum antibody neutralization and receptor binding
Sheri HarariiD, Rachel T. EguiaiD, Bernadeta DadonaiteiD, Caelan E. RadfordiD, Cameron StewartiD, David VeesleriD, Jesse D. BloomiD
Abstract
Human coronavirus 229E (HCoV-229E) is an endemic pathogen that causes repeated "common-cold" infections throughout life. Like other coronaviruses, it accumulates spike mutations that erode antibody immunity and enable reinfection. Here, we use pseudovirus deep mutational scanning to measure how mutations to the HCoV-229E spike affect its cell entry function, binding to its human APN receptor, and neutralization by human sera with a range of sensitivities to erosion by viral evolution. We find that both receptor binding and serum neutralization are affected by mutations across spike, including many that modulate these properties by affecting the balance of up versus down conformations of the spike receptor-binding domain (RBD). In particular, some mutations increase both receptor binding and serum neutralization by shifting the RBD to a more up conformation, suggesting that the HCoV-229E spike has evolved to shield key RBD neutralizing epitopes at the cost of less efficient receptor binding.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A neutralizing human antibody induces movement of the HCoV-229E receptor binding domain
Mera F. Liccione, Trevor Scobey, … Daniel Wrapp·Communications BiologyPeer-reviewed·Dec 31, 2025
- Spike mutations that affect the function and antigenicity of recent KP.3.1.1-like SARS-CoV-2 variants
Bernadeta Dadonaite, Sheri Harari, … Jesse D. Bloom·Journal of VirologyPeer-reviewed·Oct 13, 2025
- Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies
A. J. Greaney, A. N. Loes, … J. D. Bloom·bioRxiv·Dec 31, 2020
- A human coronavirus evolves antigenically to escape antibody immunity
R. Eguia, K. H. D. Crawford, … J. D. Bloom·bioRxiv·Dec 17, 2020
- The SARS-CoV-2 spike receptor-binding domain has evolved decreased inherent antigenicity in humans
Catherine Jacob-Dolan, Jim B. Boonyaratanakornkit, Jesse D. Bloom·bioRxiv·Oct 16, 2026
- Insights on SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival